BIOGEN INC. 8-K

What Happened Biogen Inc. announced its results of operations and financial condition for the second quarter ended June 30, 2026 in a press release dated July 29, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K filed under Item 2.02 (Results of Operations and Financial Condition); the filing also includes the Cover Page Interactive Data File (Exhibit 104).

Key Details

• Press release announcing Q2 results dated July 29, 2026 and covering the quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to Form 8-K (Item 2.02).
• Cover Page Interactive Data File (Inline XBRL) provided as Exhibit 104.
• Form 8-K signed by Wendell Taylor, Secretary, on July 29, 2026.

Why It Matters Quarterly results and related press releases provide the first public summary of revenue, earnings, and operational performance for the period—information investors use to assess near-term company performance and market outlook. Retail investors should read the furnished press release (Exhibit 99.1) for revenue, earnings per share, and any guidance or commentary, and watch for the company’s Form 10-Q and other SEC filings for full financial statements and management discussion and analysis.